Diabetes type 2 pandemic in 21st century

被引:1
|
作者
Ginter, E. [1 ]
Simko, V [2 ]
机构
[1] Inst Prevent & Clin Med, Bratislava, Slovakia
[2] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
关键词
diabetes type 2; increased prevalence; obesity; free fatty acids; adipokines; leptin; ACTIVATED PROTEIN-KINASE; FREE FATTY-ACIDS; CARDIOVASCULAR-DISEASE; OBESITY; RESISTANCE; RISK; AMPK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the second half of the 20th century it became obvious that a relentless increase in diabetes type 2 (DM) affecting the economically affluent countries, is gradually afflicting also the developing world. This review juxtaposes the threat that the DM epidemic represents to mankind, with the astonishing recent discoveries on the role of obesity and of the body fat in this metabolic disorder. Presently, the highest prevalence of DM is in Saudi Arabia, a country deep in riches generated by its oil wells. DM is very high, in over 10 % of adults in the USA, Switzerland and Austria. Prevalence is low in Norway, China and in Iceland. Predictions of epidemiologists for the first third of the 21st century claim up to 2.5 times increase in DM in the Middle East, Sub-Saharan Africa, India, rest of Asia and in the Latin America. In China the number of patients with DM will double but in the economically advanced countries that experienced rise in DM in the 20th century, the increase will be only about 50 %. Remarkably, a lowest increase in DM is expected in the countries that formerly belonged to the Soviet political space. Increasing urbanization, aging populations, obesity, and falling levels of physical activity are all contributing to the rise of DM worldwide. The main cause of DM pandemic is growing prevalence of obesity, in Europe and in the Latin America. In the North America obesity is considered to be responsible for 90 % of DM in females. Male obesity is associated with DM slightly less, at 70-80 % in the European Union and in the US. The precise mechanism by which obesity leads to insulin resistance and to DM is not completely described but it may be related to several biochemical factors, such as abnormalities in free fatty acids, adipokines, leptin and other substances (Tab. 1, Fig. 4, Ref. 24). Full Text (Free, PDF) www.bmj.sk.
引用
收藏
页码:134 / 137
页数:4
相关论文
共 50 条
  • [1] TYPE 2 DIABETES MELLITUS, PANDEMIC IN 21st CENTURY
    Ginter, Emil
    Simko, Vlado
    DIABETES: AN OLD DISEASE, A NEW INSIGHT, 2013, 771 : 42 - 50
  • [2] Diabetes, a 21st century pandemic
    Pou Torello, Josep Ma
    Castell Abad, Conxa
    REVISTA ROL DE ENFERMERIA, 2010, 33 (02): : 87 - 87
  • [3] Type 2 diabetes: A 21st century epidemic
    Jaacks, Lindsay M.
    Siegel, Karen R.
    Gujral, Unjali P.
    Narayan, K. M. Venkat
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (03) : 331 - 343
  • [4] Diabetes: a 21st century challenge
    Zimmet, Paul Z.
    Magliano, Dianna J.
    Herman, William H.
    Shaw, Jonathan E.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01): : 56 - 64
  • [5] SARS: the first pandemic of the 21st century
    Cherry, JD
    Krogstad, P
    PEDIATRIC RESEARCH, 2004, 56 (01) : 1 - 5
  • [6] Obesity: the real pandemic of the 21st century
    Cordova Villalobos, Jose Angel
    CIRUGIA Y CIRUJANOS, 2016, 84 (05): : 351 - 355
  • [7] SARS: The First Pandemic of the 21st Century
    James D Cherry
    Paul Krogstad
    Pediatric Research, 2004, 56 : 1 - 5
  • [8] IT and 21st Century Employment in Pandemic Times
    Strawn, George
    IT PROFESSIONAL, 2020, 22 (03) : 70 - 72
  • [9] The first influenza pandemic of the 21st century
    Al Hajjar, Sami
    McIntosh, Kenneth
    ANNALS OF SAUDI MEDICINE, 2010, 30 (01) : 1 - 10
  • [10] The prevention of type 2 diabetes - lifestyle change or pharmacotherapy? A challenge for the 21st century
    Simpson, RW
    Shaw, JE
    Zimmet, PZ
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (03) : 165 - 180